PFE Exceeds On Revenues, Falls Short Of Earnings
Pfizer (NYSE: PFE) reported its Q4 EPS at $0.49 as compared to the consensus expectations of $0.50. PFE’s revenues for the quarter came at $16.53 billion versus Street view of $15.88 billion.
PFE has forecasted its EPS for FY10 at $2.10-$2.20, missing the consensus expectations of $2.27. The company also expects its revenues for the fiscal year at $67-$69 billion versus consensus expectations of $67.47 billion.
PFE’s shares have slipped by 1.77% to trade at $18.90 in pre market.







